NeuroOne Announces 1-for-6 Reverse Stock Split Effective April 16
NeuroOne Medical Technologies will implement a 1-for-6 reverse stock split effective 5 p.m. ET April 15, 2026, with split-adjusted trading commencing April 16 under new CUSIP 64130M308. The move aims to restore compliance with Nasdaq’s minimum bid price rule, with fractional shares cashed out and equity awards proportionally adjusted.
1. Reverse Split Details
NeuroOne Medical Technologies Corporation will effect a 1-for-6 reverse stock split of its common stock at 5 p.m. ET on April 15, 2026. The split-adjusted shares will begin trading on the Nasdaq Capital Market under symbol NMTC at the opening on April 16, 2026, using new CUSIP 64130M308.
2. Compliance Rationale and Effects
The reverse split is designed to bring the company back into compliance with Nasdaq’s minimum bid price requirement. No fractional shares will be issued; holders entitled to fractions will receive cash payments, and the proportional interest of each shareholder remains unchanged except for cash-outs.
3. Stockholder Approval and Mechanics
The split was approved at the April 3, 2026 annual meeting under a board-authorized range of 1-for-2 to 1-for-15, with directors opting for a 1-for-6 ratio. Outstanding stock options and equity incentive plan shares will be adjusted proportionally to reflect the new share count without altering par value or authorized shares.